BREAKING: Pfizer/BioNTech COVID-19 shot sails through FDA panel after staffers sing its praises AstraZeneca, J&J COVID-19 shots must succeed to meet U.S. vaccination goal: Slaoui McConnell takes liability, state aid off table to get deal on COVID-19 relief package Moderna doses adolescents in COVID-19 vaccine study, setting it up to target 2021-22 school year Hackers breach Pfizer/BioNTech COVID-19 vaccine data in cyberattack targeting EMA HHS defends falling short of PPE goals on Strategic National Stockpile as some shortages linger FDA authorizes first at-home COVID-19 test available without a prescription Moody's: Outlook stable for health insurers in 2021 despite COVID-19, policy pressures Biopharma roundup: AstraZeneca, J&J shots needed for U.S. vaccination goal Healthcare roundup: CVS aiming to boost access to flu vaccines Featured Story | By Amirah Al Idrus Pfizer and BioNTech’s COVID-19 vaccine is one step closer to an emergency nod after an expert panel voted in favor of its emergency use Thursday evening. The Vaccines and Related Biologics Products Advisory Committee voted 17-4, with one panel member abstaining, that the benefits of the vaccine outweighed its risks for use in people 16 and older. read more |
| |
|---|
|
Top Stories By Arlene Weintraub COVID-19 vaccines from Pfizer and Moderna could be on the market soon, but they won't get the U.S. to its goal of vaccinating most people by summer. Operation Warp Speed co-leader Moncef Slaoui says shots from AstraZeneca and J&J could fill the gap, though some analysts are expressing doubts about AZ's chances of success. read more By Robert King Senate Majority Leader Mitch McConnell endorsed removing state and local aid as well as liability protections from a COVID-19 relief package but Democratic leadership has endorsed a bipartisan package. read more By Nick Paul Taylor Moderna has dosed the first adolescents in a phase 2/3 clinical trial designed to position its COVID-19 vaccine for use in children as young as 12 years old before the start of the 2021-22 school year. read more By Angus Liu Of all the cyberattacks that have targeted COVID-19 research, one is now known to have successfully snatched some data—from Pfizer and BioNTech's BNT162b2, the Western world’s first authorized coronavirus vaccine. read more By Robert King The Trump administration defended its stewardship of the Strategic National Stockpile after it missed a goal of having 300M N95 masks on hand. read more By Conor Hale No search for an open COVID-19 testing center. No waiting in line. No need to even venture outside the house, in fact. That's the promise of LabCorp's Pixel test, which has secured an FDA green light for home delivery without a prescription. read more By Paige Minemyer The credit outlook for health insurers is stable for next year, though several trends to watch in 2021 could have a notable financial impact, according to a new report from Moody's Investors Service. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner The U.S. needs shots from AstraZeneca and J&J, not just Pfizer and Moderna, to hit its summer vaccination goal, Warp Speed chief Moncef Slaoui said. The FDA authorized an at-home COVID test for use without a prescription. Plus, a CDC official says she was told to delete an email with evidence of political interference in CDC processes. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
